Page 50 - T-I JOURNAL19-3

610 LIN ET AL. ARGUS SYSTEM 611

SC, McCarty C, de Jong PT, Nemesure B, Mitchell G, Handa J, Barale PO< Sahel JA, Stanga PE, thesis system. Investig Ophthalmol Vis Sci. Peters T, Stingl K, Sachs H, Stett A, Szurman P,
P, Kempen J, Eye Diseases Prevalence Research Hafezi F, Safran AB, Salzmann J, Santos A, Birch 2011;52:4949. Wilhelm B, Wilke R. Subretinal electronic chips
Group. Prevalence of age-related macular degen- D, Spencer R, Cideciyan AV, de Juan E, Duncan 27. Stanga PE, Sahel JA Jr, Hafezi F, Merlini F, Coley allow blind patients to read letters and combine
eration in the United States. Arch Ophthalmol. JL, Eliott D, Fawzi A, Olmos de Koo LC, Ho B, Greenberg RJ, Argus II Study Group. Patients them to words. Proc Biol Sci. 2011;278:1489-
2004;122:564-572. AC, Brown G, Haller J, Regillo C, Del Priore LV, blinded by outer retinal dystrophies are able to 1497.
13. den Hollander AI, ten Brink JB, de Kok YJ, van ARditi A, Greenberg RJ, Argus II Study Group. perceive simultaneous colors using the Argus® II 30. Stingl K, Bartz-Schmidt KU, Gekeler F, Kusnyerik
Soest S, van den Born LI, van Driel MA, van Five-year safety and performance results from retinal prosthesis system. Investig Ophthalmol A, Sachs H, Zrenner E. Functional outcome
de Pol DJ, Payne AM, Bhattacharya SS, Kell- the Argus II retinal prosthesis system clinical Vis Sci. 2012;53:6952.
ner U, Hoyng CB, Westerveld A, Brunner HG, trial. Ophthalmology. 2016;123:2248-2254. 28. Kusnyerik A, Greppmaier U, Wilke R, Gekeler F, in subretinal electronic implants depends on
Bleeker-Wagemakers EM, Deutman AF, Heck- 21. Ho AC, Humayun MS, Dorn JD, da Cruz L, Wilhelm B, Sachs HG, Bartz-Schmidt KU, Klose foveal eccentricity. Invest Ophthalmol Vis Sci.
enlively JR, Cremers FP, Bergen AA. Mutations Dagnelie G, Handa J, Barale PO, Sahel JA, Stanga U, Stingl K, Resch MD, Hekmat A, Bruckmann 2013;54:7658-7665.
in a human homologue of Drosophila crumbs PE, Hafezi F, Safran AB, Salzmann J, Santos A, A, Karacs K, Nemeth J, Suveges I, Zrenner E. 31. Mathieson K, Loudin J, Goetz G, Huie P, Wang
cause retinitis pigmentosa (RP12). Nat Genet. Birch D, Spencer R, Cideciyan AV, de Juan E, Positioning of electronic subretinal implants L, Kamins TI, Galambos L, Smith R, Harris JS,
1999;23:217-221. Duncan JL, Eliott D, Fawzi A, Olmos de Koo in blind retinitis pigmentosa patients through Sher A, Palanker D. Photovoltaic retinal pros-
14. Humayun MS, Prince M, de Juan E, Jr., Barron LC, Brown GC, Haller JA, Regillo CD, Del Pri- multimodal assessment of retinal structures. thesis with high pixel density. Nat Photonics.
Y, Moskowitz M, Klock IB, Milam AH. Mor- ore LV, Arditi A, Geruschat DR, Greenberg RJ, Invest Ophthalmol Vis Sci. 2012;53:3748-3755. 2012;6:391-397.
phometric analysis of the extramacular retina Argus II Study Group. Long-term results from 29. Zrenner E, Bartz-Schmidt KU, Benav H, Besch D, 32. Palanker D, Vankov A, Huie P, Baccus S. Design
from postmortem eyes with retinitis pigmentosa. an epiretinal prosthesis to restore sight to the Bruckmann A, Gabel V-P, Gekeler F, Greppmaier of a high-resolution optoelectronic retinal pros-
Invest Ophthalmol Vis Sci. 1999;40:143-148. blind. Ophthalmology. 2015;122:1547-1554. U, Harscher A, Kibbel S, Koch J, Kusnyerik A, thesis. J Neural Eng. 2005;2:S105-120.
15. Kim SY, Sadda S, Pearlman J, Humayun MS, de 22. Arsiero M dCL, Merlini F, Sahel JA, Stanga, PE,
Juan E Jr, Melia BM, Green WR. Morphometric Hafezi F, Greenberg RJ, Argus II Study Group.
analysis of the macula in eyes with disciform Subjects blinded by outer retinal dystrophies
age-related macular degeneration. Retina. are able to recognize shapes using the Argus II
2002;22:471-477. retinal prosthesis system. Investig Ophthalmol
16. Lin TC, Chang HM, Hsu CC, Hung KH, Chen Vis Sci. 2011;52:4951.
YT, Chen SY, Chen SJ. Retinal prostheses in 23. da Cruz L, Coley BF, Dorn J, Merlini F, Filley
degenerative retinal diseases. J Chin Med Assoc. E, Christopher P, Chen FK, Wuyyuru V, Sahel
2015;78:501-505. J, Stanga P, Humayun M, Greenberg RJ, Dag-
17. Yue L, Falabella P, Christopher P, Wuyyuru V, nelie G, Argus II Study Group. The Argus II
Dorn J, Schor P, Greenberg RJ, Weiland JD, epiretinal prosthesis system allows letter and
Humayun MS. Ten-year follow-up of a blind word reading and long-term function in patients
patient chronically implanted with epiret- with profound vision loss. Br J Ophthalmol.
inal prosthesis Argus I. Ophthalmology. 2013;97:632-636.
2015;122:2545-2552.e2541. 24. Luo YH-L, Zhong J, Merlini F, Anaflous F, Arsi-
18. Caspi A, Dorn JD, McClure KH, Humayun ero M, Stanga PE, Da Cruz L. The use of Argus®
MS, Greenberg RJ, McMahon MJ. Feasibility II retinal prosthesis to identify common objects
study of a retinal prosthesis: spatial vision with in blind subjects with outer retinal dystrophies.
a 16-electrode implant. Arch Ophthalmol. Investig Ophthalmol Vis Sci. 2014;55:1834.
2009;127:398-401. 25. Luo YH-L, Zhong JJ, da Cruz L. The use of
19. Humayun MS, Dorn JD, da Cruz L, Dagnelie G, Argus® II retinal prosthesis by blind subjects to
Sahel JA, Stanga PE, Cideciyan AV, Duncan JL, achieve localisation and prehension of objects
Eliott D, Filley E Ho AC, Santos A, Safran AB, in 3-dimensional space. Graefes Arch Clin Exp
Arditi A, Del Priore LV, Greenberg RJ, Argus II Ophthalmol. 2015;253(11):1907-14.
Study Group. Interim results from the interna- 26. Stanga PE, Hafezi F, Sahel JA, Merlini F, Coley
tional trial of Second Sight’s visual prosthesis. B, Greenberg RJ, Argus II Study Group. Patients
Ophthalmology. 2012;119:779-788. blinded by outer retinal dystrophies are able to
20. da Cruz L, Dorn JD, Humayun MS, Dagnelie perceive color using the Argus II retinal pros-